awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24681743-5CFCEC30-E26C-4276-97E9-A1D2A6283413
Q24681743-5CFCEC30-E26C-4276-97E9-A1D2A6283413
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24681743-5CFCEC30-E26C-4276-97E9-A1D2A6283413
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
P2860
Q24681743-5CFCEC30-E26C-4276-97E9-A1D2A6283413
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24681743-5CFCEC30-E26C-4276-97E9-A1D2A6283413
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e57ad6eb639ecff9a9f498e86a10bcbebb2bd7fc
P2860
The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants